F. Diaz et al., STUDY OF SERUM PROCOLLAGEN TYPE-III PEPTIDE IN PATIENTS WITH HEPATIC CIRRHOSIS FROM A CLINICAL POINT-OF-VIEW, The Clinical investigator, 71(5), 1993, pp. 416-418
N-terminal procollagen-III peptide (P-III-P) has been considered a mar
ker of fibrogenesis and inflammatory activity of the liver. We measure
d the P-III-P serum levels in 83 cirrhotic patients fully characterize
d from a clinical and laboratory point of view. Cirrhotic patients had
significantly higher P-III-P serum levels than controls (P<0.0001). O
f the cirrhotic patients 73.5% had increased P-III-P. A significant ne
gative correlation was found between P-III-P and transaminases, and pa
tients with normal values of alanine amino-transferase had higher P-II
I-P serum levels than those with increased values (P = 0.03). On the o
ther hand, no significant association was found with portal hypertensi
on, Child classes, or alcoholic liver disease. No one independent fact
or appears to be responsible for the increase in P-III-P. The measurem
ent of serum P-III-P is of little if any use in the evaluation of cirr
hotic patients.